Press Conference

Recent Media Coverage

Read recent articles about PerkinElmer below. Clicking a headline will take you to the publication’s website for the full article.

Micro Solution to Future Developments

Since microfluidics origin, chemists and engineers have used microelectronics and analytical biochemistry concepts to generate microfluidic chips with networks of channels through which fluids move, allowing a range of analytical, synthetic and other fluidic tasks to be performed.

Molecular Pathology’s Contextual Cues

“Molecular content” is being seen as an intricate, interconnected whole, a dynamic collection of interacting parts.

Happy Birthday, ChemDraw

Like many chemists of a certain age, Derek Lowe remembers the exact moment when he learned about the chemical-structure-drawing program we now call ChemDraw.

Cell Biology Special Report: Feeling out phenotypes

Technologies such as PerkinElmer’s Opal platform and its multispectral imaging and analysis software allow researchers to multiplex immunology markers in a single assay on a single slide.

PerkinElmer joining AMRI on Buffalo biotech hub

PerkinElmer, a maker of high-tech equipment used in the pharmaceutical industry, is joining Albany Molecular Research Inc. in a new, multimillion-dollar drug development hub soon to open on the Buffalo Niagara Medical Campus.

Shelton’s PerkinElmer named an Environmental Champion for efforts

PerkinElmer of Shelton has received an Aquarion Environmental Champion Award. PerkinElmer company was recognized for its environmental efforts as well as for encouraging employees to participate voluntarily internal and external environmental projects.

GEN Roundup on Kinase Assays

Kinase assays that are compatible with high-throughput screening techniques are essential.

Saving Umbilical Cord Blood

MACON, Ga- "A child with sickle cell has a lot of complications,” says Dominique Gissel. “She would have to live with it all her life.

PerkinElmer beats 1Q profit forecasts

WALTHAM, Mass. (AP) _ PerkinElmer Inc. (PKI) on Thursday reported first-quarter profit of $40.3 million. On a per-share basis, the Waltham, Massachusetts-based company said it had net income of 36 cents.

Genetic Disorder Screening System Granted Chinese Market Clearance

PerkinElmer Inc, Waltham, Mass, a global leader focused on improving the health and safety of people and the environment, recently received clearance from the China Food and Drug Administration to bring to market its genetic screening processor (GSP) and GSP neonatal hTSH reagent kit.